Literature DB >> 23639381

Molecular characterization of Group A streptococcal isolates causing scarlet fever and pharyngitis among young children: a retrospective study from a northern Taiwan medical center.

Po-Chuang Wu1, Wen-Tsung Lo1, Shyi-Jou Chen1, Chih-Chien Wang2.   

Abstract

BACKGROUND/
PURPOSE: Little information is available on the differences in frequency of pyrogenic exotoxin genes between strains of group A streptococci that cause scarlet fever and those that cause pharyngotonsillitis in children in Taiwan. This study retrospectively monitored the presence of pyrogenic exotoxin genes, the emm typing, and the susceptibility of macrolide drugs in Streptococcus pyogenes isolated from children diagnosed with scarlet fever and pharyngotonsillitis in northern Taiwan.
MATERIALS AND METHODS: Isolates of S. pyogenes were recovered from children with scarlet fever (n = 21) and acute pharyngotonsillitis (n = 29) during 2000-2011. The isolates were characterized according to the presence of spe genes and emm typing. Antibiograms were determined by the disk diffusion method and agar dilution test. Polymerase chain reaction was used to detect the presence of erm genes in isolates that showed nonsusceptibility to erythromycin. All isolates underwent additional genotyping by pulsed-field gel electrophoresis.
RESULTS: In isolates from patients with scarlet fever, the frequencies of pyrogenic exotoxin genes were 9.5% for speA, 81.0% for speB, 4.8% for speC, and 71.4% for speF. In isolates from patients with pharyngotonsillitis, the frequencies were 17.2% for speA, 72.4% for speB, 13.8% for speC, and 69.0% for speF. There were no significant differences in frequencies of the exotoxin genes between the two groups of isolates. Eight emm sequence types were identified from all group A streptococci isolates. The most common types were emm12 followed by emm1 and emm4. The erythromycin resistant rate was 4/50 (8%). The ermB gene was detected in only one isolate from a patient with pharyngotonsillitis. Pulsed-field gel electrophoresis had a total of three sets of clustered strains, which showed >80% homology and belonged to the same emm type.
CONCLUSION: There were no significant differences in frequencies of the spe genes between S. pyogenes isolates from patients with scarlet fever and patients with pharyngotonsillitis. The most common emm type was emm12. Low erythromycin resistance in S. pyogenes was observed.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Scarlet fever; Streptococcal pyrogenic exotoxin; Streptococcus pyogenes

Mesh:

Substances:

Year:  2013        PMID: 23639381     DOI: 10.1016/j.jmii.2013.02.007

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  5 in total

1.  In vivo Acquisition of Carbapenemase Gene blaKPC-2 in Multiple Species of Enterobacteriaceae through Horizontal Transfer of Insertion Sequence or Plasmid.

Authors:  Baixing Ding; Zhen Shen; Fupin Hu; Meiping Ye; Xiaogang Xu; Qinglan Guo; Minggui Wang
Journal:  Front Microbiol       Date:  2016-10-21       Impact factor: 5.640

2.  Detection of Group A Beta Hemolytic Streptococci Species, emm, and Exotoxin Genes Isolated from Patients with Tonsillopharyngitis.

Authors:  Mehzat Altun; Binnur Mericli Yapıcı
Journal:  Curr Microbiol       Date:  2020-05-04       Impact factor: 2.188

3.  Assessment of the Relationship between Clinical Manifestation and Pathogenic Potential of Streptococcus pyogenes Strains-Distribution of Genes and Genotypes of Toxins.

Authors:  Tomasz Bogiel; Alicja Domian; Zuzanna Dobrzyńska; Agnieszka Mikucka; Eugenia Gospodarek-Komkowska
Journal:  Biomedicines       Date:  2022-03-29

4.  Group A streptococcal strains isolated in Lao People's Democratic Republic from 2004 to 2013.

Authors:  S Rattanavong; D A B Dance; V Davong; C Baker; H Frost; R Phetsouvanh; M Vongsouvath; P N Newton; A C Steer; P R Smeesters
Journal:  Epidemiol Infect       Date:  2015-12-09       Impact factor: 2.451

5.  The Comeback of Scarlet Fever.

Authors:  Samson S Y Wong; Kwok-Yung Yuen
Journal:  EBioMedicine       Date:  2018-01-31       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.